Environmental, Social, And Governance Report

Overview

The report presents Chimeric's purpose as discovering, developing and commercialising novel cell therapies with curative potential. It reports 7 employees at the end of the reporting period and states that the company has never reported a work-related fatality. GHG emissions, TCFD implementation and water consumption are not currently considered material stakeholder capitalism metrics because of the company's small workforce and office footprint. Its FY23 performance table reports 100% governance compliance and $14,432,338 in total R&D expenses.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2023
Period: Ends 30 June 2023
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

Other

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services